Related Experiment Video
Updated: May 23, 2026
09:11
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
Hybrid options for treating cardiac disease
Ramanan Umakanthan1, Marzia Leacche, David X Zhao
1Department of Cardiac Surgery, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee 37232-8802, USA.
Seminars in Thoracic and Cardiovascular Surgery
|March 27, 2012
Summary
Hybrid technology integrates interventional cardiology and cardiac surgery, offering new treatments for heart disease. This approach enhances collaboration and introduces innovative hybrid operating rooms for complex cardiac conditions.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Surgical Innovation
Background:
- The last 2.5 decades have seen significant advancements in cardiac disease treatment options.
- Hybrid technology represents a convergence of interventional cardiology and cardiac surgery.
- This integration addresses complex cardiovascular conditions, including coronary artery disease, valve disease, and atrial fibrillation.
Purpose of the Study:
- To explore the impact and evolution of hybrid technology in treating cardiac disease.
- To highlight the development of novel techniques and specialized hybrid operating rooms.
- To emphasize the enhanced collaboration between interventional cardiologists and cardiac surgeons.
Main Methods:
- Review of advancements in hybrid cardiac treatment over the past 2.5 decades.
- Description of the integration of interventional cardiology catheterization laboratories and cardiac surgery operating rooms.
- Analysis of new procedural suites designed for hybrid interventions.
Main Results:
- Significant expansion of treatment options for various heart conditions.
- Development of innovative techniques for complex coronary artery disease, valve disease, and atrial fibrillation.
- Establishment of dedicated hybrid operating rooms facilitating combined procedures.
Conclusions:
- Hybrid technology has revolutionized cardiac disease management by merging interventional and surgical approaches.
- The advent of hybrid operating rooms and collaborative teams has improved patient care.
- Continued innovation in hybrid techniques promises further advancements in cardiovascular medicine.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...